Abbott Laboratories
In Nicolai Tangen's portfolio · Norges Bank Investment Management
Ticker ABT
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Norges Bank Investment Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2025 | Add 4% | 23,456,714 | 0.3% |
| Q3 2025 | Add 1% | 22,554,928 | 0.3% |
| Q2 2025 | Add 2% | 22,249,689 | 0.4% |
| Q1 2025 | Add 4% | 21,760,762 | 0.4% |
| Q1 2024 | Add 5% | 20,177,599 | 0.4% |
| Q4 2023 | Add 3% | 19,222,637 | 0.4% |
| Q3 2023 | Add 1% | 18,711,853 | 0.4% |
| Q2 2023 | Add 4% | 18,442,754 | 0.4% |
| Q4 2022 | Add 6% | 17,248,522 | 0.5% |
| Q3 2022 | Add 2% | 16,236,464 | 0.4% |
| Q2 2022 | Reduce 4% | 15,860,665 | 0.4% |
| Q1 2022 | Add 1% | 16,483,033 | 0.4% |
| Q4 2021 | Reduce 1% | 16,276,274 | 0.5% |
| Q3 2021 | Reduce 1% | 16,481,003 | 0.4% |
| Q2 2021 | Reduce 3% | 16,645,395 | 0.4% |
| Q1 2021 | No change | 17,103,732 | 0.5% |
| Q4 2020 | No change | 17,184,330 | 0.4% |
| Q3 2020 | No change | 17,167,616 | 0.5% |
| Q2 2020 | Add 1% | 17,168,521 | 0.5% |
| Q1 2020 | Add 1% | 17,042,657 | 0.5% |
| Q4 2019 | Reduce 5% | 16,845,773 | 0.4% |
| Q3 2019 | Reduce 1% | 17,750,279 | 0.5% |
| Q2 2019 | Add 7% | 17,902,775 | 0.5% |
| Q1 2019 | Reduce 2% | 16,769,827 | 0.4% |
| Q4 2018 | Reduce 3% | 17,136,096 | 0.5% |
| Q3 2018 | Reduce 4% | 17,747,564 | 0.4% |
| Q2 2018 | Add 4% | 18,407,595 | 0.4% |
| Q1 2018 | Reduce 5% | 17,671,909 | 0.4% |
| Q4 2017 | Reduce 3% | 18,518,132 | 0.4% |
| Q3 2017 | No change | 19,081,206 | 0.4% |
| Q2 2017 | Add 7% | 19,145,658 | 0.4% |
| Q3 2012 | Add 1% | 12,310,492 | 0.6% |
| Q2 2012 | First 13F | 12,244,463 | 0.7% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.